Intellectual Property India Publishes Patent Application for 'An Improved Process For The Preparation Of N-(4,5-Dimethylisoxazol-3-Yl)-N-(Methoxymethyl)-2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2- Yl)Benzenesulfonamide' Filed by MSN Laboratories Private Limited, R&D Center

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202441007236 A) filed by MSN Laboratories Private Limited, R&D Center, Hyderabad, Telangana, on Feb. 2, 2024, for 'an improved process for the preparation of n-(4,5-dimethylisoxazol-3-yl)-n-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- yl)benzenesulfonamide.'

Inventor(s) include Srinivasan Thirumalai Rajan; Gade Srinivas Reddy; and Mokenapelli Sudhakar.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "An improved process for the preparation of N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide The present invention relates to an improved process for the preparation of N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzenesulfonamide of formula-1 which is the key intermediate for Sparsentan Formula-1."

Disclaimer: Curated by HT Syndication.